Skip to Content

Recombinant Zoster Vaccine (Shingrix)

Last Updated: April 16, 2020
Status: Current

Products Affected - Description
    • Shingrix, GlaxoSmithKline, 0.5 mL vial, 1 count, NDC 58160-0819-12
    • Shingrix, GlaxoSmithKline, 0.5 mL vial, 10 count, NDC 58160-0823-11
Reason for the Shortage
    • GlaxoSmithKline has Shingrix on shortage due to high demand for the product.
Available Products
    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • GlaxoSmithKline has Shingrix on allocation with regular releases.

Updated

Updated April 16, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. Created May 17, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide